Modeling Economic Effects of Vaccination Against Porcine Reproductive and Respiratory Syndrome: Impact of Vaccination Effectiveness, Vaccine Price, and Vaccination Coverage.
PRRS control
disease intervention
economic modeling
pig production
vaccination effectiveness
Journal
Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658
Informations de publication
Date de publication:
2020
2020
Historique:
received:
29
04
2020
accepted:
02
07
2020
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
28
8
2020
Statut:
epublish
Résumé
Porcine reproductive and respiratory syndrome (PRRS) causes substantial financial losses in pig farms and economic losses to societies worldwide. Vaccination against PRRS virus (PRRSV) is a common intervention in affected farms. The aim of this study was to assess the economic impact and profitability of potential new PRRS vaccines with improved efficacy at animal, herd, and national level. Two vaccination strategies were modeled; (i) mass vaccination of sows only (MS) and (ii) mass vaccination of sows and vaccination of piglets (MSP), comprising different scenarios of vaccine effectiveness, vaccine price, and vaccination coverage. A farrow-to-finish farm with 1,000 working sows from a pig-dense region in Germany served as an example farm. Financial benefits were obtained from gross margin analyses and were defined as difference in gross margin between a PRRSV-infected farm without vaccination (baseline) and with vaccination (intervention). Financial benefits were highest if both sows and piglets (MSP) were vaccinated. In these scenarios, median annual net benefits per working sow ranged from €170 to 340. If sows only were vaccinated (MS), estimated benefits attributable to vaccination were between €148 and 270. Decisive variables for the estimation of national level benefits were the number of farmers switching from existing to a better protecting vaccine, the number of previously non-vaccinating herds adopting the new vaccine, and the effectiveness of the new vaccine relative to those already available. Benefits were greatest when the new vaccine was adopted by previously non-vaccinating herds. The analyses showed that vaccination against PRRS was beneficial for all modeled scenarios. The magnitude of benefits derived from vaccination was more susceptible to changes in vaccination effectiveness than to vaccine price changes. This study provides evidence to support future vaccine development. The estimates indicate that the introduction of more efficient vaccines might lead to substantial financial benefits, is of socio-economic importance and that new vaccines might significantly contribute to the reduction of disease burden.
Identifiants
pubmed: 32851052
doi: 10.3389/fvets.2020.00500
pmc: PMC7431490
doi:
Types de publication
Journal Article
Langues
eng
Pagination
500Informations de copyright
Copyright © 2020 Thomann, Rushton, Schuepbach-Regula and Nathues.
Références
Rev Sci Tech. 1999 Aug;18(2):315-42
pubmed: 10472671
Vaccine. 2009 Jun 8;27(28):3704-18
pubmed: 19464553
Epidemiol Rev. 1994;16(1):77-89
pubmed: 7925730
J Am Vet Med Assoc. 2005 Aug 1;227(3):385-92
pubmed: 16121604
Vaccine. 2015 Jun 17;33(27):3065-72
pubmed: 25980425
Vet Microbiol. 2018 Nov;226:89-96
pubmed: 30389048
Porcine Health Manag. 2016 May 9;2:12
pubmed: 28405438
Vet Rec. 2012 Mar 3;170(9):225
pubmed: 22238201
J Anim Sci. 2019 Jul 30;97(8):3213-3227
pubmed: 31212312
Front Microbiol. 2017 Aug 28;8:1635
pubmed: 28894443
Viruses. 2019 Jun 25;11(6):
pubmed: 31242645
Health Policy Plan. 2012 May;27 Suppl 2:ii62-76
pubmed: 21733989
Front Vet Sci. 2017 Nov 09;4:189
pubmed: 29170739
Prev Vet Med. 2018 Apr 1;152:89-102
pubmed: 29559110
Front Vet Sci. 2020 Jan 15;6:488
pubmed: 32010711
Hum Vaccin. 2010 Aug;6(8):619-26
pubmed: 20861678
Prev Vet Med. 2017 Jul 1;142:16-29
pubmed: 28606362
Viruses. 2019 Jun 14;11(6):
pubmed: 31207934
Vaccine. 2020 Mar 23;38(14):3050-3061
pubmed: 32122719
Front Vet Sci. 2019 Jun 18;6:190
pubmed: 31275949
Front Vet Sci. 2017 Sep 01;4:129
pubmed: 28920059
J Anim Sci. 2016 Feb;94(2):514-22
pubmed: 27065121
Virus Res. 2010 Dec;154(1-2):1-6
pubmed: 20951175
Porcine Health Manag. 2019 Jun 11;5:13
pubmed: 31183160
PLoS One. 2019 Aug 30;14(8):e0220738
pubmed: 31469850